ALBIREO PHARMA, INC. Toevoegen aan een lijst
Grafiek agenda Albireo Pharma, Inc.
2e065d45868f.y6aMW5_bgfxC9xQlOervmaEALPEHKLUlsgaJN_wHkLg.iuHaNv2Z1MUQpyJ_TrDX9e1kRZV1XNFLwjLoXNE32-mY7f8X-622vjCyYw~9b7f648e0f439160f1d1a75d87424b97
Komende gebeurtenissen op Albireo Pharma, Inc.
Geen evenementen beschikbaar
Gebeurtenissen op naam
| 15-11-2022 11:20 | Jefferies London Healthcare Conference |
| 08-11-2022 22:30 | Q3 2022 Presentatie van de resultaten |
| 08-11-2022 | Q3 2022 Cijferpublicaties Nabeurs |
| 07-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 07-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 07-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 07-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 07-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 06-11-2022 20:10 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 06-11-2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 18-10-2022 16:30 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 15-10-2022 20:00 | NASPGHAN Meeting |
| 15-10-2022 18:00 | NASPGHAN Meeting - Abstract Number : 547 |
| 14-10-2022 19:45 | NASPGHAN Meeting |
| 14-10-2022 18:00 | NASPGHAN Meeting - Abstract Number : 301 |
| 13-10-2022 23:00 | NASPGHAN Meeting - Abstract Number : 70 |
| 11-10-2022 14:30 | Bylvay Phase 3 Trial Results Call |
| 28-09-2022 14:30 | Guggenheim Therapeutics Conference |
| 13-09-2022 14:30 | Baird Global Healthcare Conference |
| 12-09-2022 16:30 | Morgan Stanley Global Healthcare Conference |
Meer evenementen
